{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:35:00Z","timestamp":1770482100378,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010275","name":"Deutsche Gesellschaft f\u00fcr Muskelkranke","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010275","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jneuroim.2013.09.006","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T02:00:46Z","timestamp":1379469646000},"page":"114-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Disturbed B cell subpopulations and increased plasma cells in myasthenia gravis patients"],"prefix":"10.1016","volume":"264","author":[{"given":"Siegfried","family":"Kohler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Oskar Philipp","family":"Keil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Swierzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Schaffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Carsten","family":"R\u00fcckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Hiepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.09.006_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ana.410140504","article-title":"Prognosis of ocular myasthenia","volume":"14","author":"Bever","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0020","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein\u2013Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mus.22103","article-title":"The thymus in myasthenia gravis: site of \u201cinnate autoimmunity\u201d?","volume":"44","author":"Cavalcante","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0025","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1749-6632.1987.tb51317.x","article-title":"The course of myasthenia gravis and therapies affecting outcome","volume":"505","author":"Grob","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0030","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/art.10273","article-title":"The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus","volume":"46","author":"Huang","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0040","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.10949","article-title":"Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus","volume":"48","author":"Jacobi","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/ard.2008.096495","article-title":"HLA-DRhigh\/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus","volume":"69","author":"Jacobi","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0045","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/mus.22080","article-title":"Practice parameters and focusing research: plasma exchange for myasthenia gravis","volume":"43","author":"Kaminski","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0050","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.188.9.1679","article-title":"Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells","volume":"188","author":"Klein","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0055","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0060","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/eji.201142306","article-title":"The early cellular signatures of protective immunity induced by live viral vaccination","volume":"42","author":"Kohler","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0065","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s00415-009-5120-8","article-title":"Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up","volume":"256","author":"Kupersmith","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0075","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archneur.1996.00550080128020","article-title":"Beneficial effects of corticosteroids on ocular myasthenia gravis","volume":"53","author":"Kupersmith","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archneur.60.2.243","article-title":"Development of generalized disease at 2years in patients with ocular myasthenia gravis","volume":"60","author":"Kupersmith","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0080","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/intimm\/10.9.1359","article-title":"Experimental autoimmune myasthenia gravis induction in B cell-deficient mice","volume":"10","author":"Li","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0085","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clim.2007.10.001","article-title":"Decrease of CD4(+)CD25(high)Foxp3(+) regulatory T cells and elevation of CD19(+)BAFF-R(+) B cells and soluble ICAM-1 in myasthenia gravis","volume":"126","author":"Li","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WCO.0b013e3282f4098e","article-title":"Ocular myasthenia: diagnostic and treatment recommendations and the evidence base","volume":"21","author":"Luchanok","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00041327-200312000-00002","article-title":"Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis","volume":"23","author":"Mee","year":"2003","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2003.08.017","article-title":"The effect of prednisone on the progression from ocular to generalized myasthenia gravis","volume":"217","author":"Monsul","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0105","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","article-title":"Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus","volume":"165","author":"Odendahl","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0110","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood-2004-07-2507","article-title":"Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response","volume":"105","author":"Odendahl","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0115","first-page":"497","article-title":"Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients","volume":"38","author":"Osserman","year":"1971","journal-title":"Mt. Sinai J. Med."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0125","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/WNL.42.5.1076","article-title":"Effect of clinical status and treatment on the frequency of CD5+ B cells in patients with myasthenia gravis","volume":"42","author":"Ragheb","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/08916939908993860","article-title":"Cell-surface expression of lymphocyte activation markers in myasthenia gravis","volume":"31","author":"Ragheb","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0130","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar3042","article-title":"Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients","volume":"12","author":"Rodriguez-Bayona","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0135","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1212\/WNL.31.8.935","article-title":"Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology","volume":"31","author":"Scadding","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF00381353","article-title":"Correlation of acetylcholine receptor antibodies and clinical severity of myasthenia gravis in combined immunosuppressive therapy","volume":"234","author":"Schumm","year":"1984","journal-title":"Eur. Arch. Psychiatry Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0145","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3587::AID-IMMU3587>3.0.CO;2-Y","article-title":"Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis","volume":"28","author":"Shi","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/jnnp.62.2.156","article-title":"Ocular myasthenia gravis: response to long-term immunosuppressive treatment","volume":"62","author":"Sommer","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"Toyka","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0165","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(78)90073-9","article-title":"In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis","volume":"1","author":"Vincent","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0170","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","article-title":"A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus","volume":"178","author":"Wei","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0175","first-page":"378","article-title":"Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes","volume":"54","author":"Willcox","year":"1983","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0180","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/WNL.42.5.1081","article-title":"Levels of CD5+ B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals","volume":"42","author":"Yi","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.09.006_bb0185","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J. Exp. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813002488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813002488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:21:24Z","timestamp":1759047684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813002488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0165572813002488"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.09.006","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disturbed B cell subpopulations and increased plasma cells in myasthenia gravis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}